GLP-1 receptor agonists in diabetes and weight loss: the double-edged sword of innovation and risks

GLP-1 receptor agonists in diabetes and weight loss: the double-edged sword of innovation and risks

Saved in:

Bibliographic Details
Main Authors:	Ioannis Ilias, Lina Zabuliene, Manfredi Rizzo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Clinical Diabetes and Healthcare
Subjects:	glucagon-like peptide-1 receptor agonists obesity weight loss diabetes adverse drug reaction pancreatitis
Online Access:	https://www.frontiersin.org/articles/10.3389/fcdhc.2024.1530811/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of GLP-1 Receptor Agonists on Perceived Eating Behaviors in Response to Stimuli
by: Cheney C, et al.
Published: (2025-05-01)

Current and potential use of GLP-1R agonists: beyond type 2 diabetes
by: Graciela Zambrano-Galván, et al.
Published: (2024-10-01)

The hidden impact of GLP‐1 receptor agonists on endometrial receptivity and implantation
by: Alberto Sola‐Leyva, et al.
Published: (2025-02-01)

Adverse effects of GLP – 1 Receptor Agonists
by: Anna Kasprzak, et al.
Published: (2025-02-01)

Unlocking the potential of GLP-1 receptor agonists in ocular therapeutics: from molecular pathways to clinical impact
by: Zhixuan Xie, et al.
Published: (2025-07-01)

Effects of GLP‐1 Receptor Agonists on Paediatric Population in a Real World Setting
by: A. G. Barajas, et al.
Published: (2025-05-01)

Exploring the Side Effects of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning
by: Jung A Kim, et al.
Published: (2025-07-01)

Improving Reproductive Outcomes in PCOS: The Emerging Role of GLP-1 Receptor Agonists
by: Adrianna Tabeau, et al.
Published: (2025-03-01)

Decreased incidence of hidradenitis suppurativa and psoriasis in diabetic patients treated with GLP-1 receptor agonists: A retrospective cohort study
by: Lauren M. Ching, BS, et al.
Published: (2025-10-01)

The expanding role of GLP-1 receptor agonists: a narrative review of current evidence and future directions
by: Areesha Moiz, et al.
Published: (2025-08-01)

Antidiabetic GLP-1 Receptor Agonists Have Neuroprotective Properties in Experimental Animal Models of Alzheimer’s Disease
by: Melinda Urkon, et al.
Published: (2025-04-01)

GLP-1 and Its Role in Glycogen Production: A Narrative Review
by: Joseph Lotosky, et al.
Published: (2025-06-01)

Efficacy and safety of GLP-1 agonists in the treatment of T2DM: A systematic review and network meta-analysis
by: Xiaoyu Ren, et al.
Published: (2025-07-01)

GLP-1 receptor agonists in Parkinson’s disease: an updated comprehensive systematic review with meta-analysis
by: Mohamed Mohsen Helal, et al.
Published: (2025-08-01)

Association of Glucagon‐Like Peptide Agonist Therapy With Dietary Patterns in a Cross‐Sectional Cohort
by: Eric J. Brandt, et al.
Published: (2025-06-01)

One step closer to solving the mystery of the anti‐inflammatory effects of glucagon‐like peptide‐1 receptor agonists
by: Hirotaka Watada
Published: (2025-02-01)

Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Venous Thromboembolism: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
by: Yiwen Liu, et al.
Published: (2025-05-01)

Nutritional priorities to support GLP-1 therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society
by: Dariush Mozaffarian, et al.
Published: (2025-09-01)

The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review
by: Michael Nunns, et al.
Published: (2025-06-01)

Mitigating Increased Cardiovascular Risk in Patients with Obstructive Sleep Apnea Using GLP-1 Receptor Agonists and SGLT2 Inhibitors: Hype or Hope?
by: Paschalis Karakasis, et al.
Published: (2024-11-01)

Nephroprotective potential of glucagon-like peptide-1 receptor agonists
by: Minara S. Shamkhalova, et al.
Published: (2020-04-01)

Meta-analysis of the efficacy of glucagon-like peptide-1 receptor agonists in the treatment of diabetic nephropathy
by: Ze-jin Liao, et al.
Published: (2024-12-01)

Dionysus or apollo, skeletal muscle mass changes in type 2 diabetes with sarcopenia receiving GLP-1 receptor agonist: systematic review and meta-analysis
by: Yanying Wang, et al.
Published: (2025-08-01)

Emerging role of GLP-1 agonists in cardio-metabolic therapy - Focus on Semaglutide
by: Celestine Odigwe, et al.
Published: (2025-04-01)

A comparison of Glucagon-like peptide-1 receptor agonists on weight change, side effects, and quality of life in Kuwait
by: Saleh Alali, et al.
Published: (2025-05-01)

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and cardiometabolic protection: historical development and future challenges
by: Francisco Westermeier, et al.
Published: (2025-01-01)

Enhanced renoprotective effects of combined glucagon‐like peptide‐1 receptor agonists and sodium‐glucose cotransporter 2 inhibitors in type 2 diabetes mellitus: Real‐world evidence
by: Jian‐Yu Jhu, et al.
Published: (2025-02-01)

Long-term cancer risk in users of GLP-1 agonists in Denmark: a nationwide emulated trialResearch in context
by: Mads Gamborg, et al.
Published: (2025-08-01)

What Are the Experiences, Views and Perceptions of Patients, Carers and Clinicians of Glucagon‐like Peptide‐1 Receptor Agonists (GLP‐1 RAs)? A Scoping Review
by: Sam Febrey, et al.
Published: (2025-04-01)

The Expanding Role of GLP-1 Receptor Agonists: Advancing Clinical Outcomes in Metabolic and Mental Health
by: Mohamad Al Qassab, et al.
Published: (2025-04-01)

A clinical case of asymptomatic pancreatic hyperenzymemia on the background of taking a Glucagon-like peptide-1 analogue (GLP-1)
by: N.A. Sanina, et al.
Published: (2023-09-01)

SGLT2 Inhibitors and GLP-1 Receptor Agonists in Diabetic Kidney Disease: Evolving Evidence and Clinical Application
by: Jae Hyun Bae
Published: (2025-05-01)

Semaglutide and the Retina
by: Zachary T. Bloomgarden
Published: (2025-04-01)

Endocrine and metabolic effects of GLP-1 receptor agonists on women with PCOS, a narrative review
by: Marine Monney, et al.
Published: (2025-03-01)

Use of Glucagon-Like Peptide-1 Receptor Agonists Does Not Increase the Risk of Cancer in Patients with Type 2 Diabetes Mellitus
by: Mijin Kim, et al.
Published: (2025-01-01)

Glucagon-like peptide-1 receptor agonist-induced cholecystitis and cholelithiasis: a real-world pharmacovigilance analysis using the FAERS database
by: Chao Tao, et al.
Published: (2025-07-01)

Exploring the multifaceted roles of GLP-1 receptor agonists; a comprehensive review
by: Bisma Fatima Hammad, et al.
Published: (2025-07-01)

Glucagon-like peptide-1 receptor agonists: a review from a cardiovascular perspective
by: Yosra Turkistani
Published: (2025-04-01)

Suicide and suicide attempt in users of GLP-1 receptor agonists: a nationwide case-time-control studyResearch in context
by: Julien Bezin, et al.
Published: (2025-02-01)

Incretin hormone agonists as promising antiobesity drugs - review of literature
by: Aleksandra Grzegorczyk, et al.
Published: (2025-01-01)